earningsconfidence high
Hims & Hers Q1 net loss $92.1M; revenue $608M (+4% YoY); raises FY2026 guidance to $2.8B-$3.0B
Hims & Hers Health, Inc.
2026-Q1 EPS
reported -$0.40
vs consensus $0.04
▼ miss
(-1005.0%)
- Revenue $608.1M (+4% YoY); net loss $92.1M vs net income $49.5M in Q1 2025.
- Adjusted EBITDA $44.3M vs $91.1M; gross margin fell to 65% from 73%.
- Subscribers 2.584M (+9% YoY); monthly revenue per subscriber $80 (-6%).
- FY2026 revenue guidance raised to $2.8B–$3.0B; Adjusted EBITDA guidance $275M–$350M.
- Proposed acquisition of Eucalyptus expected mid-2026; not included in guidance.
item 2.02item 9.01
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.